左室補助循環装置（LVAD）の世界市場

左室補助循環装置（LVAD）の世界市場は2030年までに26億米ドルに到達

2023年に15億米ドルと推定される左室補助循環装置（LVAD）の世界市場は、分析期間2023-2030年にCAGR 7.6%で成長し、2030年には26億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである病院エンドユーズは、CAGR 6.1％を記録し、分析期間終了までに13億米ドルに達すると予測されます。診療所エンドユースセグメントの成長率は、分析期間中CAGR 9.9%と推定されます。

米国市場は4億2,340万米ドルと推定、中国はCAGR 7.2％で成長予測

米国の左室補助循環装置（LVAD）市場は、2023年に4億2,340万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR7.2％を追いかけ、2030年までに4億270万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.8%と6.4%と予測されています。欧州では、ドイツがCAGR約6.2％で成長すると予測されています。

世界の左室補助循環装置（LVAD）市場- 主要動向と促進要因まとめ

左室補助循環装置（LVAD）とは何か？

左室補助循環装置（LVAD）は、心臓が弱っている人や重症心不全の人の心臓機能と血流をサポートするために使用される機械的ポンプです。LVADは通常、治療が有効でなくなった場合に使用され、心臓移植への橋渡しとして、患者がドナーの心臓を待つ間、重要なサポートを提供します。あるいは、移植の候補でない患者には、LVADを目的療法として使用し、標準治療として長期的なサポートを提供することもできます。これらの装置は外科的に植え込まれ、左心室から血液を取り出して大動脈に送り、心臓の主室のポンプ機能を効果的に補助または代行することで機能します。LVAD技術の進歩により、患者のQOLと生存率は大幅に改善され、この装置は進行した心不全を管理する上で極めて重要な選択肢となっています。

技術革新はLVAD市場をどのように形成しているか？

LVADの設計と機能性における技術的進歩は、その有効性と患者適合性を劇的に向上させました。最新のLVADは、よりコンパクトで侵襲性が低く、血栓や感染症などのデバイス関連合併症のリスクを低減する連続流技術を備えています。磁気ベアリングや流体力学的ベアリングなどの技術革新は、装置の物理的摩耗を最小限に抑え、使用可能な寿命と信頼性を延長しています。さらに、バッテリーの寿命や携帯性の向上により、制限の多かった以前のモデルよりも、患者の自由度や可動性が高まった。このような技術的改善により、LVADの普及率が高まっただけでなく、高齢の患者や複雑な健康プロファイルを持つ患者など、LVAD植込みの潜在的な候補者層も広がっています。

LVAD市場にはどのような課題と機会があるのか？

大きな進歩にもかかわらず、LVAD市場は患者の転帰と幅広い普及の両方に影響する課題に直面しています。移植手技の侵襲的な性質と出血、脳卒中、感染などの重篤な合併症のリスクは、潜在的な候補者を躊躇させるかなりの懸念事項です。さらに、装置本体、手術、術後のケアを含む新興諸国のLVADのコストは、特に後進国においては、多くの患者やヘルスケアシステムにとって法外に高いままです。しかし、このような課題は、市場における革新と成長の機会にもなっています。これらの問題に対処しうる、より低侵襲で信頼性が高く、費用対効果の高い機器を生み出すための研究開発が常に求められています。患者の転帰を大幅に改善できる可能性があるため、現在の限界を克服できる次世代LVADの開発への投資と関心が引き続き高まっています。

LVAD市場の成長はいくつかの要因によって促進される

LVAD市場の成長は、人口動態の動向、技術の進歩、ヘルスケアの進化を反映した複数の要因によって牽引されています。世界の心不全の有病率の増加は、世界人口の高齢化と相まって、LVADのような高度な治療オプションに対する需要の増加をもたらしています。これらのデバイスを使用する患者の安全性とQOLを高める技術革新は、デバイスを患者と臨床医の双方にとってより魅力的なものにする主要な促進要因です。さらに、患者選択と術前ケアの改善により、LVAD患者の転帰が最適化され、この治療法の成功率と信頼性が高まっています。最後に、いくつかの国ではヘルスケア支出の増加と先進医療に対する保険適用範囲の拡大により、LVADがより幅広い患者に利用されるようになり、市場の成長をさらに刺激しています。これらの要因が総合的にLVAD市場のダイナミックな拡大に寄与しており、LVADは現代の心臓治療に不可欠な要素となっています。

調査対象企業の例（計13社）

• Evaheart, Inc.
• Peripal AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• その他の地域

第4章 競合

Global Left Ventricular Assist Device (LVAD) Market to Reach US$2.6 Billion by 2030

The global market for Left Ventricular Assist Device (LVAD) estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Clinics End-Use segment is estimated at 9.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$423.4 Million While China is Forecast to Grow at 7.2% CAGR

The Left Ventricular Assist Device (LVAD) market in the U.S. is estimated at US$423.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$402.7 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Left Ventricular Assist Device (LVAD) Market - Key Trends & Drivers Summarized

What Are Left Ventricular Assist Devices (LVADs) and How Do They Support Heart Health?

Left Ventricular Assist Devices (LVADs) are mechanical pumps used to support heart function and blood flow in individuals with weakened hearts or severe heart failure. Typically employed when medical treatments are no longer effective, LVADs can be used as a bridge to heart transplantation, providing vital support while a patient awaits a donor heart. Alternatively, for patients who are not candidates for transplantation, LVADs can be used as a destination therapy, offering long-term support as a standard of care. These devices are surgically implanted and work by taking blood from the left ventricle and pumping it to the aorta, effectively aiding or taking over the pumping function of the heart's main chamber. Advances in LVAD technology have significantly improved the quality of life and survival rates for patients, making these devices a crucial option in managing advanced heart failure.

How Is Technological Innovation Shaping the LVAD Market?

Technological advancements in the design and functionality of LVADs have dramatically enhanced their effectiveness and patient compatibility. Modern LVADs are more compact, less invasive, and equipped with continuous flow technology that reduces the risk of device-related complications, such as blood clots and infections. Innovations such as magnetic and hydrodynamic bearings have minimized the physical wear on the device, extending their usable life and reliability. Additionally, improvements in battery life and portability allow patients more freedom and mobility than earlier models, which were more restrictive. These technological improvements have not only increased the adoption rates of LVADs but have also broadened the potential candidate pool for LVAD implantation, including older patients and those with complex health profiles.

What Challenges and Opportunities Exist Within the LVAD Market?

Despite significant advancements, the LVAD market faces challenges that affect both patient outcomes and broader adoption. The invasive nature of the implantation procedure and the risk of serious complications such as bleeding, stroke, and infection are considerable concerns that can deter potential candidates. Moreover, the cost of LVADs, including the device itself, surgery, and post-operative care, remains prohibitively high for many patients and healthcare systems, particularly in less developed countries. However, these challenges also present opportunities for innovation and growth within the market. There is a constant demand for research and development to produce less invasive, more reliable, and cost-effective devices that could address these issues. The potential for significant improvements in patient outcomes continues to drive investment and interest in developing next-generation LVADs that could overcome current limitations.

Growth in the LVAD Market Is Driven by Several Factors

The growth in the LVAD market is driven by several factors, reflecting a combination of demographic trends, technological advancements, and evolving healthcare practices. Increasing prevalence of heart failure worldwide, coupled with an aging global population, has resulted in a higher demand for advanced treatment options like LVADs. Technological innovations that enhance the safety and quality of life for patients using these devices are key growth drivers, making the devices more appealing to both patients and clinicians. Additionally, improvements in patient selection and pre-operative care have optimized outcomes for LVAD recipients, increasing the success rates and confidence in this treatment approach. Finally, growing healthcare expenditures and expanding insurance coverage for advanced medical treatments in several countries are making LVADs accessible to a broader range of patients, further stimulating market growth. These factors collectively contribute to the dynamic expansion of the LVAD market, making it a vital component of modern cardiac care.

Select Competitors (Total 13 Featured) -

• Evaheart, Inc.
• Peripal AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Left Ventricular Assist Device (LVAD) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Left Ventricular Assist Device (LVAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Left Ventricular Assist Device (LVAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Left Ventricular Assist Device (LVAD) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 16: USA 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: Canada 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• JAPAN
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: Japan 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• CHINA
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: China 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• EUROPE
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Left Ventricular Assist Device (LVAD) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• FRANCE
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: France 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• GERMANY
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: Germany 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: Italy 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: UK 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Rest of Europe Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Rest of Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Asia-Pacific Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Asia-Pacific 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of World Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Rest of World 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION